
Asymmetrx
Free shipping on orders over $99 · 30-day returns
PROSTATE-63 CANCER DIAGNOSTIC TEST is an FDA 510(k)-cleared medical device (K050063) manufactured by Asymmetrx. This device is classified under the Hematology specialty. FDA Device Class I (General Controls) — lowest risk category. FDA clearance granted on February 8, 2005. Regulation: 8.